179 related articles for article (PubMed ID: 36300779)
1. A novel
Li J; Zhang Y; Li J; Xu Y; Zhang G
Haematologica; 2023 Feb; 108(2):627-632. PubMed ID: 36300779
[No Abstract] [Full Text] [Related]
2. Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.
Ha JS; Do YR; Ki CS; Lee C; Kim DH; Lee W; Ryoo NH; Jeon DS
Leukemia; 2017 Sep; 31(9):1992-1995. PubMed ID: 28555082
[No Abstract] [Full Text] [Related]
3. Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia.
Qin YZ; Huang XJ; Zhu HH
Leukemia; 2018 Oct; 32(10):2285-2287. PubMed ID: 29568099
[No Abstract] [Full Text] [Related]
4. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
Such E; Cervera J; Valencia A; Barragán E; Ibañez M; Luna I; Fuster O; Perez-Sirvent ML; Senent L; Sempere A; Martinez J; Martín-Aragonés G; Sanz MA
Blood; 2011 Jan; 117(1):242-5. PubMed ID: 20935257
[TBL] [Abstract][Full Text] [Related]
5. A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.
Chen X; Wang F; Zhang Y; Teng W; Cao P; Ma X; Liu M; Tian Y; Wang T; Nie D; Zhang J; Liu H; Wang W
Br J Cancer; 2019 May; 120(11):1023-1025. PubMed ID: 30996344
[TBL] [Abstract][Full Text] [Related]
6. A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia.
Luo H; Zhang S; Li K; Chen XH; Li YC; Sun Y; Liu LF; Yu HY; Zhu HH
Leuk Res; 2019 Feb; 77():14-16. PubMed ID: 30612054
[No Abstract] [Full Text] [Related]
7. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
8. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
9. Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion.
Kirkham JK; Liu YC; Foy SG; Ma J; Gheorghe G; Furtado LV; Popescu MI; Klco JM; Karol SE; Blackburn PR
Genes Chromosomes Cancer; 2023 Oct; 62(10):617-623. PubMed ID: 37283355
[TBL] [Abstract][Full Text] [Related]
10. Report of PRPF19 as a novel partner of RARG and the recurrence of interposition-type fusion in variant acute promyelocytic leukemia.
Wu H; Li H; Zhou X; Zhao Z; Cao P; Li L; Ma X; Yuan L; Wang F; Zhang Y; Chen J; Fang J; Liu M; Liu M; Chen X; Liu H
Hematol Oncol; 2023 Oct; 41(4):784-788. PubMed ID: 37132198
[TBL] [Abstract][Full Text] [Related]
11. Genetics of APL and the molecular basis of retinoic acid treatment.
Casini T; Grignani F; Pelicci PG
Int J Cancer; 1997 Feb; 70(4):473-4. PubMed ID: 9033658
[No Abstract] [Full Text] [Related]
12. APL, a model disease for cancer therapies?
de Thé H; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
[No Abstract] [Full Text] [Related]
13. The biology of acute promyelocytic leukemia.
Mann KK; Shao W; Miller WH
Curr Oncol Rep; 2001 May; 3(3):209-16. PubMed ID: 11296130
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Zhang JW; Wang JY; Chen SJ; Chen Z
J Biosci; 2000 Sep; 25(3):275-84. PubMed ID: 11022230
[TBL] [Abstract][Full Text] [Related]
15. Recurrent RARG trinary fusion and ligand binding domain truncation in variant acute promyelocytic leukemia resistant to retinoic acid but sensitive to homoharringtonine-based therapy.
Chen X; Zhao Y; Zhou X; Chen J; Cao P; Wang F; Zhang Y; Wu P; Zhang L; Liu H
Int J Lab Hematol; 2023 Dec; 45(6):1016-1019. PubMed ID: 37605819
[No Abstract] [Full Text] [Related]
16. Retinoid differentiation therapy in promyelocytic leukemia.
Chomienne C; Fenaux P; Degos L
FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
[TBL] [Abstract][Full Text] [Related]
17. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
Rashidi A; Fisher SI
Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
[No Abstract] [Full Text] [Related]
18. Identification of novel recurrent CPSF6-RARG fusions in acute myeloid leukemia resembling acute promyelocytic leukemia.
Liu T; Wen L; Yuan H; Wang Y; Yao L; Xu Y; Cen J; Ruan C; Wu D; Chen S
Blood; 2018 Apr; 131(16):1870-1873. PubMed ID: 29487068
[No Abstract] [Full Text] [Related]
19. Differentiation therapy of acute promyelocytic leukemia.
Chen Z
Chin Med J (Engl); 1996 Mar; 109(3):179-82. PubMed ID: 8758302
[No Abstract] [Full Text] [Related]
20. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
Nason-Burchenal K; Allopenna J; Bègue A; Stéhelin D; Dmitrovsky E; Martin P
Blood; 1998 Sep; 92(5):1758-67. PubMed ID: 9716606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
